GlobeNewswire

2024-06-26 23:49

Vicor wins preliminary injunction against Foxconn subsidiaries

ANDOVER, Mass., June 26, 2024 (GLOBE NEWSWIRE) -- Vicor Corporation (NASDAQ: VICR) today announced that, on June 24, 2024, the United States District Court for the District of Massachusetts granted a preliminary injunction barring subsidiaries of Foxconn from pursuing arbitration against Vicor before the China International Economic and Trade Arbitration Commission (“CIETAC”).

The Foxconn subsidiaries had sought to obtain a ruling from CIETAC that small print in their purchase orders for Vicor power modules entitled them to royalty-free licenses to Vicor patents, including patents asserted in a pending investigation in the United States International Trade Commission (“ITC”). An ITC exclusion order could bar from entry into the United States infringing power converter modules (“NBMs”) and systems containing such modules, including artificial intelligence ("AI") accelerators, tensor processing units ("TPU"), graphical processing units ("GPU") and central processing units ("CPU").

In the district court action, which resulted in a temporary restraining order and a preliminary injunction, Vicor is represented by Fish & Richardson P.C.

For more information on Vicor, please visit the company’s website at www.vicorpower.com.

About Vicor

Vicor Corporation designs, develops, manufactures and markets modular power components and complete power systems based upon a portfolio of patented technologies. Headquartered in Andover, Massachusetts, Vicor sells its products to the power systems market, including enterprise and high performance computing, industrial equipment and automation, telecommunications and network infrastructure, vehicles and transportation, aerospace and defense. www.vicorpower.com

Vicor is a registered trademark of Vicor Corporation.

For more information contact:

Phil Davies
Corporate Vice President, Global Sales and Marketing
pdavies@vicorpower.com


Primary Logo

source: Vicor Corporation

【你點睇?】《施政報告》提出醫療改革,盧寵茂表示日後普通科門診擬只接受弱勢群體,你是否支持?► 立即投票

人氣文章
財經新聞
評論
專題
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

【etnet 30周年】多重慶祝活動一浪接一浪,好禮連環賞!

【etnet30周年連環賞】睇住賞維柏健webber naturals ®健骨MSM(活絡配方) (價值HK$412)

etnet榮獲HKEX Awards 2023 「最佳證券數據供應商」大獎

大國博弈

貨幣攻略

傾力救市

說說心理話

Watche Trends 2024

北上食買玩

Art Month 2024

理財秘笈

秋天養生食療

消委會報告

山今養生智慧

輕鬆護老